lung cancer Archive — Page 13 of 16
-
November 21, 2013
Untangling RAS
An “undruggable” cancer-causing protein, 30 years of research and the national initiative that aims to finally make the connections -
October 10, 2013
Probing mutant EGF receptor regulation
Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. -
September 12, 2013
VU study identifies DNA changes in drug-resistant cancer cells
Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. -
August 1, 2013
Study explores race differences of lung cancer risk
Vanderbilt research scientist Melinda Aldrich, Ph.D., MPH, has been awarded a National Institutes of Health Academic Career Award to investigate some of the genetic secrets behind a greater risk of lung cancer among African-Americans compared with other racial and ethnic groups. -
June 27, 2013
Recent Publications by VICC Researchers
-
June 27, 2013
My Cancer Genome
-
June 27, 2013
Seven Survivors